by Clare Gerrard | Jul 17, 2023
The Big Cancer52 Conversation on Wednesday 14th June brought together leaders from the charity, healthcare and pharmaceutical sectors, to share best practices, exchange ideas and explore collaborations, with the ultimate aim of improving outcomes for people with rare... by Clare Gerrard | Jul 14, 2023
Name: Kate Neuroendocrine Cancer site: Tail of pancreas and secondaries in the liver KATE’S STORY Hello, my name is Kate and I have been living with neuroendocrine cancer for 13 years. I feel lucky to be here to see my family grow up. It took three visits to the GP to... by Clare Gerrard | May 9, 2023
Neuroendocrine cancers (NC) are England’s tenth most prevalent cancer. Yet awareness of these cancers is very low, even among healthcare professionals (HCPs). People living with NC experience inequities in diagnosis, disease management and care due to a lack of... by Clare Gerrard | Apr 26, 2023
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012 & 2018: A Retrospective, Population-Based Study : published 20th March 2023. A retrospective, population-based study comparing overall survival (OS) between males and females with... by Clare Gerrard | Mar 20, 2023
NETs for Newcomers 18th May 2023 Birmingham Neuroendocrine Cancer UK is delighted to take part in UKINETs 6th annual NETs for Newcomers : Introduction to Neuroendocrine Cancer Medicine and Management. This CPD accredited course is designed for doctors, of all... 
